EUVIMEDEUVIMED entdecken
Crossref

Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole

Krishnakumar P, Sankar Chandra Mondal, Hema Rath, Kamaldeep Chawla

Hypertension Journal · 22.02.2025 · 10 (4) · 94-99

DOI: 10.61081/htnj/24v10i403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension Journal, online erschienen am 22.02.2025. Verfasst von Krishnakumar P und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

P, K., Mondal, S. C., Rath, H., & Chawla, K. (2025). Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole. Hypertension Journal, 10(4), 94-99. https://doi.org/10.61081/htnj/24v10i403

Vancouver

P K, Mondal SC, Rath H, Chawla K. Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole. Hypertension Journal. 2025;10(4):94-99. doi:10.61081/htnj/24v10i403

BibTeX
@article{P2025,
  author = {P, Krishnakumar and Mondal, Sankar Chandra and Rath, Hema and Chawla, Kamaldeep},
  title = {Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole},
  journal = {Hypertension Journal},
  year = {2025},
  volume = {10},
  number = {4},
  pages = {94--99},
  doi = {10.61081/htnj/24v10i403}
}
Kostenlos starten →